menu search

BDSI / Why the Earnings Surprise Streak Could Continue for BioDelivery (BDSI)

Why the Earnings Surprise Streak Could Continue for BioDelivery (BDSI)
BioDelivery (BDSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. Read More
Posted: Feb 7 2022, 13:53
Author Name: Zacks Investment Research
Views: 111556

BDSI News  

Has BioDelivery Sciences International (BDSI) Outpaced Other Medical Stocks This Year?

By Zacks Investment Research
March 18, 2022

Has BioDelivery Sciences International (BDSI) Outpaced Other Medical Stocks This Year?

Here is how BioDelivery Sciences International (BDSI) and Vertex Pharmaceuticals (VRTX) have performed compared to their sector so far this year. more_horizontal

Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline

By Zacks Investment Research
March 2, 2022

Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline

BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared wi more_horizontal

Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline

By Zacks Investment Research
March 2, 2022

Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline

BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared wi more_horizontal

Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline

By Zacks Investment Research
March 2, 2022

Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline

BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared wi more_horizontal

BioDelivery (BDSI) Stock Surges on Buyout Offer From Collegium

By Zacks Investment Research
February 15, 2022

BioDelivery (BDSI) Stock Surges on Buyout Offer From Collegium

Collegium (COLL) is set to acquire BioDelivery (BDSI) for approximately $604 million in cash. The transaction is likely to be completed by the end of more_horizontal

BioDelivery (BDSI) Stock Surges on Buyout Offer From Collegium

By Zacks Investment Research
February 15, 2022

BioDelivery (BDSI) Stock Surges on Buyout Offer From Collegium

Collegium (COLL) is set to acquire BioDelivery (BDSI) for approximately $604 million in cash. The transaction is likely to be completed by the end of more_horizontal

BioDelivery (BDSI) Stock Surges on Buyout Offer From Collegium

By Zacks Investment Research
February 15, 2022

BioDelivery (BDSI) Stock Surges on Buyout Offer From Collegium

Collegium (COLL) is set to acquire BioDelivery (BDSI) for approximately $604 million in cash. The transaction is likely to be completed by the end of more_horizontal

BDSI Stock Alert: The Deal Sending Little-Known BioDelivery Skyrocketing Today

By InvestorPlace
February 14, 2022

BDSI Stock Alert: The Deal Sending Little-Known BioDelivery Skyrocketing Today

Today, a big takeover announcement has sent shares of BioDelivery and BDSI stock soaring more than 50% on investor enthusiasm for this deal. The post more_horizontal


Search within

Pages Search Results: